deoxy · news / FDA Press Releases

   
 
 Home · About · Category · CloudToday · Digest · MyNews · Search

          
FDA Press Releases
Tue May 22 16:48:41 2012 GMT
  » FEEDSITE

  • FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions
  • U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC
  • FDA approves generic versions of blood thinner Plavix
  • FDA expands use for FilmArray Respiratory Panel
  • FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
  • FDA proposal aims to help reduce unnecessary radiation exposure for children
  • FDA issues final rule on sterility testing of biological products
  • FDA permits marketing of a new device for abdominal surgery
  • FDA approves new orphan drug to treat a form of Gaucher disease
  • FDA approves new antibacterial treatment for plague
  • FDA approves Stendra for erectile dysfunction
  • FDA challenges marketing of DMAA products for lack of safety evidence
  • FDA approves Votrient for advanced soft tissue sarcoma
  • FDA approves Afinitor for non-cancerous kidney tumors caused by rare genetic disease
  • FDA Statement on USDA Announcement of Positive BSE Test Result
  • FDA strengthens international collaboration to ensure quality, safety of imported products
  • Report: FDA strengthens monitoring of post-approval drug safety
  • FDA issues draft guidance on nanotechnology